Gabapentin neuroprotection and seizure suppression in immature mouse brain ischemia

Pediatric Research

Volumn 64, Issue 1, 2008, Pages 81-85

  Traa, Beatrix S ^a   Mulholland, Justin D ^a   Kadam, Shilpa D ^a,b   Johnston, Michael V ^a,b   Comi, Anne M ^a,b  

^a KENNEDY KRIEGER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; 4 AMINOBUTYRIC ACID; AMINE; ANTICONVULSIVE AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; BRAIN ATROPHY; BRAIN ISCHEMIA; CAROTID ARTERY LIGATION; CD1 MOUSE; CEREBROVASCULAR ACCIDENT; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; EXPERIMENTAL MOUSE; FEMALE; HEMISPHERE; LOW DRUG DOSE; MALE; MOUSE; MOUSE STRAIN; NEUROPROTECTION; NONHUMAN; PEDIATRICS; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; SEIZURE; ANIMAL; ANIMAL BEHAVIOR; ATROPHY; BODY TEMPERATURE; BRAIN; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; INTRAPERITONEAL DRUG ADMINISTRATION; NEWBORN; PATHOLOGY; SEX DIFFERENCE;

AMINES; ANIMALS; ANIMALS, NEWBORN; ANTICONVULSANTS; ATROPHY; BEHAVIOR, ANIMAL; BODY TEMPERATURE; BRAIN; BRAIN ISCHEMIA; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GAMMA-AMINOBUTYRIC ACID; INJECTIONS, INTRAPERITONEAL; MALE; MICE; NEUROPROTECTIVE AGENTS; SEIZURES; SEX FACTORS;

EID: 49849097382     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e318174e70e     Document Type: Article

References (36)

1. Lynch JK, Nelson KB 2001 Epidemiology of perinatal stroke. Curr Opin Pediatr 13:499-505
2. Giroud M, Lemesle M, Gouyon JB, Nivelon JL, Milan C, Dumas R 1995 Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features fromto 1993 to 1985. J Clin Epidemiol 48:1343-1348
3. Schoenberg BS 1979 Risk factors for stroke in infants and children. Adv Neurol 25:313-324
4. Comi AM, Weisz CJ, Highet BH, Johnston MV, Wilson MA 2004 A new model of stroke and ischemic seizures in the immature mouse. Pediatr Neurol 31:254-257
5. Comi AM, Johnston MV, Wilson MA 2005 Strain variability, injury distribution and seizure onset in a mouse model of stroke in the immature brain. Dev Neurosci 27:127-133
6. Comi AM, Highet BH, Mehta P, Hana CT, Johnston MV, Wilson MA 2006 Dextromethorphan protects male but not female mice with brain ischemia. Neuroreport 17:1319-1322
7. Koelfen W, Freund M, Varnholt V 1995 Neonatal stroke involving the middle cerebral artery in term infants: clinical presentation, EEG and imaging studies, and outcome. Dev Med Child Neurol 37:204-212
8. Delsing BJ, Catsman-Berrevoets CE, Appel IM 2001 Early prognostic indicators of outcome in ischemic childhood stroke. Pediatr Neurol 24:283-289
9. Johnston MV, Hoon AH Jr 2000 Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies. J Child Neurol 15:588-591
10. Downen M, Belkowski S, Knowles H, Cardillo M, Prystowsky MB 1999 Developmental expression of voltage-gated potassium channel beta subunits. Brain Res Dev Brain Res 117:71-80
11. Jensen FE 2002 The role of glutamate receptor maturation in perinatal seizures and brain injury. Int J Dev Neurosci 20:339-347
12. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH 1994 Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529-540
13. Rice JE III, Vannucci RC, Brierley JB 1981 The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9:131-141
14. Comi AM 2005 Neuroprotection for Ischemic injury in the immature brain. Curr Pediatr Rev 1:135-145
15. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ 2005 Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 365:663-670
16. Morrison RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA, Schwartzkroin PA 1996 Loss of the p53 tumor suppressor gene protects neurons from kainate- induced cell death. J Neurosci 16:1337-1345
17. Calabresi P, Cupini LM, Centonze D, Pisani F, Bernardi G 2003 Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Ann Neurol 53:693-702
18. Wasterlain CG, Adams LM, Hattori H, Schwartz PH 1992 Felbamate reduces hypoxic-ischemic brain damage in vivo. Eur J Pharmacol 212:275-278
19. Wasterlain CG, Adams LM, Schwartz PH, Hattori H, Sofia RD, Wichmann JK 1993 Posthypoxic treatment with felbamate is neuroprotective in a rat model of hypoxia- ischemia. Neurology 43:2303-2310
20. Hayakawa T, Hamada Y, Maihara T, Hattori H, Mikawa H 1994 Phenytoin reduces neonatal hypoxic-ischemic brain damage in rats. Life Sci 54:387-392
21. Lampley EC Jr, Mishra OP, Graham E, Delivoria-Papadopoulos M 1995 Neuropro- tective effect of phenytoin against in utero hypoxic brain injury in fetal guinea pigs. Neurosci Lett 186:192-196
22. Hayakawa T, Higuchi Y, Nigami H, Hattori H 1994 Zonisamide reduces hypoxic- ischemic brain damage in neonatal rats irrespective of its anticonvulsive effect. Eur J Pharmacol 257:131-136
23. Papazisis G, Kallaras K, Kaiki-Astara A, Pourzitaki C, Tzachanis D, Dagklis T, Kouvelas D 2007 Neuroprotection by lamotrigine in a rat model of neonatal hypoxic-ischaemic encephalopathy. Int J Neuropsychopharmacol:1-9
24. Liu Y, Qin N, Reitz T, Wang Y, Flores CM 2006 Inhibition of the rat brain sodium channel Nav1.2 after prolonged exposure to gabapentin. Epilepsy Res 70:263-268
25. Bertrand S, Nouel D, Morin F, Nagy F, Lacaille JC 2003 Gabapentin actions on Kir3 currents and N-type Ca2+ channels via GABAB receptors in hippocampal pyramidal cells. Synapse 50:95-109
26. Davies A, Hendrich J, Van Minh AT, Wratten J, Douglas L, Dolphin AC 2007 Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels. Trends Pharmacol Sci 28:220-228
27. Bucay AH 2007 Use of gabapentin during pregnancy to reduce brain damage in new-born infants that are premature or at risk of perinatal asphyxia. Med Hypotheses 68:1422
28. Johnston MV, Hagberg H 2007 Sex and the pathogenesis of cerebral palsy. Dev Med Child Neurol 49:74-78
29. Zhu C, Xu F, Wang X, Shibata M, Uchiyama Y, Blomgren K, Hagberg H 2006 Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia-ischaemia. J Neurochem 96:1016-1027
30. Du L, Bayir H, Lai Y, Zhang X, Kochanek PM, Watkins SC, Graham SH, Clark RS 2004 Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway. J Biol Chem 279:38563-38570
31. Renolleau S, Fau S, Goyenvalle C, Joly LM, Chauvier D, Jacotot E, Mariani J, Charriaut-Marlangue C 2007 Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: a role for gender. J Neurochem 100:1062-1071
32. Bowles DK 2001 Gender influences coronary L-type Ca(2+) current and adaptation to exercise training in miniature swine. J Appl Physiol 91:2503-2510
33. Bowles DK, Maddali KK, Ganjam VK, Rubin LJ, Tharp DL, Turk JR, Heaps CL 2004 Endogenous testosterone increases L-type Ca2 + channel expression in porcine coronary smooth muscle. Am J Physiol Heart Circ Physiol 287:H2091-H2098
34. Hall J, Jones TH, Channer KS, Jones RD 2006 Mechanisms of agonist-induced constriction in isolated human mesenteric arteries. Vascul Pharmacol 44:427433
35. Boyd RA, Turck D, Abel RB, Sedman AJ, Bockbrader HN 1999 Effects of age and gender on single-dose pharmacokinetics of gabapentin. Epilepsia 40:474-479
36. Radulovic LL, Turck D, von Hodenberg A, Vollmer KO, McNally WP, DeHart PD, Hanson BJ, Bockbrader HN, Chang T 1995 Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys. Drug Metab Dispos 23:441-448